Filter posts

Beyond the ABCs of ADCs

The recent FDA approval of Seattle Genetics’ antibody, Adcetris, has cast the spotlight on Antibody …

Multiple Assets Diversify the Deal

With a recent surge in pharma companies collaborating earlier on with small biotech companies, discovery …

Medical Innovation at Risk

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists …

Boosting Investment in Biotech

The President’s Council on Jobs and Competitiveness issued an interim report with suggestions to increase …

BioWorld previews BIO India: India Emerges as Global Player via Multinational Partnering

BioWorld’s Tom Wall interviewed BIO’s Alan Eisenberg (subscription required) on what attendees can expect at …

The Burrill Report: Pushing Policies in a Changed Washington

The Burrill Report’s Daniel Levine talks to BIO’s Alan Eisenberg regarding recent fluctuations in the …

BioCentury TV at BIO International Convention

BioCentury TV interviewed biotech leaders throughout the recent BIO International Convention in Washington, DC. The …

Quandary for U.S. companies: Whom to bribe? (Washington Post)

From this Sunday’s Washington Post, David Hilzenrath lays out ambiguities of the Foreign Corrupt Practices …

Public Opinion: What do voters think about biotechnology?

The majority of voters recognize the important work being conducted at biotech companies and place …

International groups put the “International” in BIO International Convention

The international presence at the global event for biotechnology was in full-force this year, with …